JPMorgan Chase & Co. Increases Stake in Nu Skin Enterprises, Inc. (NYSE:NUS)

JPMorgan Chase & Co. grew its position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 74.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 405,667 shares of the company's stock after buying an additional 173,710 shares during the period. JPMorgan Chase & Co. owned approximately 0.82% of Nu Skin Enterprises worth $2,795,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Barclays PLC increased its holdings in Nu Skin Enterprises by 363.8% in the 3rd quarter. Barclays PLC now owns 85,437 shares of the company's stock worth $629,000 after buying an additional 67,016 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Nu Skin Enterprises by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,487 shares of the company's stock valued at $8,333,000 after acquiring an additional 11,838 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of Nu Skin Enterprises in the third quarter worth approximately $93,000. Range Financial Group LLC purchased a new position in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $117,000. Finally, Ballentine Partners LLC lifted its position in Nu Skin Enterprises by 15.5% during the fourth quarter. Ballentine Partners LLC now owns 20,856 shares of the company's stock valued at $144,000 after purchasing an additional 2,800 shares during the period. Institutional investors own 82.84% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th.

Nu Skin Enterprises Price Performance

NYSE NUS opened at $5.52 on Wednesday. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $274.47 million, a P/E ratio of -1.87 and a beta of 1.10. The company has a 50-day moving average price of $7.17 and a 200-day moving average price of $6.96. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $14.00.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. The business had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Equities research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 4.35%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is currently -8.14%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.